Launch Sale20% off everythingShop now
Research Use OnlyAll products are sold strictly for laboratory research — not for human consumption.

Growth Hormone & Body Composition · Research Use Only

Sermorelin

Also known as: GRF(1-29), GHRH(1-29)

Sermorelin is a GHRH(1-29) fragment analog comprising the biologically active N-terminal segment of growth-hormone-releasing hormone, studied in preclinical GH-axis research.

View Sermorelin product →

What is Sermorelin?

Sermorelin, also written as GRF(1-29) or GHRH(1-29), is a synthetic analog corresponding to the first 29 amino acids of growth-hormone-releasing hormone. This N-terminal fragment is considered the biologically active core of the native hormone.

By reproducing the shortest active sequence of GHRH, Sermorelin is used in research as a compact analog that engages the GHRH receptor upstream of growth-hormone release.

It is popularly associated in anti-aging, biohacking, and fitness communities with restoring youthful growth-hormone output to support recovery, sleep, and body composition.

Purported Benefits & Research Focus

Sermorelin is a growth-hormone-releasing hormone (GHRH) fragment that is reputed among anti-aging and wellness enthusiasts for its purported ability to stimulate the pituitary's own GH production rather than supplying hormone directly. It is anecdotally reported to support recovery, energy, and healthier body composition.

Researchers are investigating GHRH analogs for their influence on IGF-1, lean mass, fat loss, and age-related decline in GH secretion, and sermorelin is frequently discussed in longevity and biohacking circles. The community popularly associates it with improved sleep quality, skin and connective-tissue support, and overall vitality.

Its appeal lies in a more physiologic, pulsatile approach to GH support that draws interest for anti-aging protocols; even so, these are areas of active or preclinical investigation and community interest, not outcomes established in humans.

How Sermorelin is studied

Preclinical research examines Sermorelin's action at the GHRH receptor and the downstream stimulation of the GH axis. Studies in laboratory and animal models measure receptor activity and hormonal markers, and often use it as a reference GHRH-fragment analog when comparing newer, longer-acting variants.

Such observations reflect mechanisms measured under research conditions and are not indicative of human outcomes.

Handling, reconstitution & storage

Sermorelin is provided lyophilized and held at -20°C in a sealed, light-protected vial. For research it is reconstituted with bacteriostatic or sterile water, after which it is kept at 4°C for short-term handling or aliquoted at -80°C for extended storage. A certificate of analysis with HPLC data accompanies each lot.

Not sure which solvent to use? See the reconstitution guide for a per-peptide breakdown of bacteriostatic vs acetic acid water.

Frequently asked questions

  • What part of GHRH does Sermorelin represent?

    It corresponds to the first 29 amino acids — GHRH(1-29) — the biologically active N-terminal fragment that engages the GHRH receptor in models.

  • How is Sermorelin stored before use?

    Lyophilized at -20°C protected from light; once reconstituted, at 4°C short-term or aliquoted at -80°C for longer research storage.

References

Related research peptides

Shop research-grade Sermorelin, HPLC-tested with a COA on every batch.

View Sermorelin

All information here is provided for laboratory and research reference only. Products are sold strictly for in-vitro research and development and are not for human or veterinary use.